Sign Up
HB 1805 Hawaii House · 2020 Regular Session

RELATING TO PRESCRIPTION DRUGS.

Summary
Requires prescription drug manufacturers to notify prescription drug benefit plans and pharmacy benefit managers if a proposed increase in the wholesale acquisition cost of certain drugs would result in a percentage increase of ten per cent or more than the percentage change in the Consumer Price Index over a twoyear period. Requires prescription drug manufacturers to notify prescription drug benefit plans and pharmacy benefit managers if a proposed reduction in rebates will result in a percentage increase of the net cost of the prescription drug of ten per cent or more, even if there is no change to the wholesale acquisition cost. Requires the drug manufacturer to identify and report to the insurance commissioner information on certain drugs whose wholesale acquisition cost increases by a certain amount during a specified time frame. (SD2)
Bill status passed both 4 of 5 stages cleared
Introduction
Jan 2020
Committee Review
Mar 2020
House Passage
Mar 2020
Senate Passage
Jul 2020
Governor
Introduced Jan 16, 2020 Last action Jul 8, 2020
Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
25
Key actions
7
Committee
7
Amendments
4
Jul 8, 2020
Introduced
House disagrees with Senate amendment (s).
lower
Jul 8, 2020
Introduced
Returned from Senate (Sen. Com. No. 614) in amended form (SD 2).
lower
Jul 8, 2020
Upper · Passed
Passed Third Reading, as amended (SD 2). Ayes, 24; Aye(s) with reservations: none . Noes, 0 (none). Excused, 0 (none). Transmitted to House.
upper
Jul 6, 2020
Upper · Passed
Floor amendment adopted as amended (SD 2).
upper
Jul 6, 2020
Introduced
Floor Amendment No. 11 offered.
upper
Mar 13, 2020
Upper · Passed
The committee(s) on CPH recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in CPH were as follows: 6 Aye(s): Senator(s) Baker, S. Chang, Ruderman, L. Thielen, Wakai, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) Nishihara.
upper
Mar 12, 2020
Upper · Passed
The committee(s) on CPH deferred the measure until 03-13-20 9:30AM in conference room 229.
upper
Mar 6, 2020
Upper · Passed
The committee(s) on CPH has scheduled a public hearing on 03-12-20 9:30AM in conference room 229.
upper
Mar 5, 2020
Committee
Referred to CPH.
upper
Mar 5, 2020
Introduced
Received from House (Hse. Com. No. 299).
upper
Mar 3, 2020
Lower · Passed
Passed Third Reading with none voting aye with reservations; none voting no (0) and Representative(s) Creagan excused (1). Transmitted to Senate.
lower
Feb 25, 2020
Lower · Passed
The committees on CPC recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 8 Ayes: Representative(s) Takumi, Ichiyama, Aquino, Cachola, Har, Kong, Mizuno, Onishi; Ayes with reservations: none; Noes: none; and 3 Excused: Representative(s) Belatti, Cabanilla Arakawa, Matsumoto.
lower
Feb 10, 2020
Committee
Re-referred to CPC, referral sheet 23
lower
Jan 21, 2020
Committee
Referred to HLT, CPC, referral sheet 2
lower
Jan 17, 2020
Introduced
Introduced and Pass First Reading.
lower
Jan 16, 2020
Introduced
Pending introduction.
lower
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.